News

Izmir Biomedicine and Genome Center (IBG): Research in life sciences in Turkey

Izmir Biomedicine and Genome Center (IBG): Research in life sciences in Turkey
Learn more about Izmir Biomedicine and Genome Center (IBG), the newest member to join our gobal community.
Partnerships and Growth
Member News

Izmir Biomedicine and Genome Center (IBG) is the first independent thematic Research Infrastructure in life sciences in Izmir, Türkiye. IBG’s main objective is to carry out powerful research on biomedicine and genome sciences, to develop products based on medical and pharmaceutical biotechnologies using its workforce and technical infrastructure, and thus, to contribute to global science and the transformation of national industry. IBG offers a broad range of research services for both academia and industry across various research fields under the below core facilities and technology platforms; Gene Targeting and Transgenic Models Platform, IBG-BIP, Bioinformatics Platform, IBG-Biobank, National node of BBMRI-ERIC, IBG-PHARMA, Drug Analysis and Control Laboratory, GLP-certified, IBG-NEVCELL, Cellular Therapies Platform, GMP Manufacturing Facility, Vivarium (Zebrafish &Rodent Unit), Rare and Undiagnosed Disease Platform. IBG has been coordinating two national high-technology platforms specializing in the design of novel adjuvants and vaccines, drug development and pan-cancer therapies.

 

As of 2023, IBG hosts 32 research groups in three main pillars (i) Basic and translational research program, (ii) Technological research program, (iii) Industrial R&D program with a research focus in the fields of cancer, genomics and bioinformatics, stem cells and regeneration, immunology and infectious diseases, rare and undiagnosed diseases, neuroscience and bioengineering.

 

IBG believes that fostering strong connections and collaborations is crucial for the success of our collective initiatives. IBG is interested in leveraging the diverse expertise within the ECHAlliance community to facilitate knowledge exchange, collaborative projects, and the sharing of best practices. Establishing robust networking channels would enable them to collectively address challenges, explore innovative solutions, and contribute to the advancement of healthcare and digital health initiatives. IBG looks forward to engaging with fellow members to build meaningful connections and collaborations that will benefit the entire community.

NEWS​

Related News

Focus on medication adherence and enabling an independent life at home for polypharmacy patients

9 Jan 2025
Meet Evondos in trade shows.

Revolutionizing Pediatric Prosthetics: A Ten-Year Journey in Bionic Technology

9 Jan 2025
This article explores the significant advancements in bionic prosthetics for children over the past decade, highlighting the transformative impact of ...

DHI Industry Engagement Plan 2024 – 2027

7 Jan 2025
DHI is pleased to unveil its Industry Engagement Plan. It describes the evolution, substance, and intended implementation of DHI's refreshed approach ...

New Report: Evaluating Digital Interventions for ADHD Diagnosis and Management in Adults within the UK

7 Jan 2025
This report explores digital interventions for managing and diagnosing adult ADHD in the UK (excluding Scotland).

Why a pioneering community mental wealth approach in Moray could put Scotland on the global wellbeing map

7 Jan 2025
Globally, more than one billion people are affected by mental health challenges and Scotland is no exception. Close to £1 million is being invested to...

Accelerate your digital start-up in 2025, join TheHill’s NHS Market Access Accelerator

7 Jan 2025
TheHill have an opportunity for digital health start-ups to gain a better understanding of how the NHS works and to build a strong foundation for futu...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *